Induction of Longitudinal Cross-Clade Anti-H5N1 Immunity and Protection by Homologous and Heterologous Prime-Boost Immunization Regimes with Whole Virus H5N1 Influenza Candidate vaccines

被引：0
|
作者：
Sabarth, N.
Howard, M. K.
van Maurik, A.
Savidis-Dacho, H.
Barrett, P. N.
Kistner, O.
机构：
来源：
VACCINE | 2008年
关键词：
H5N1; influenza; Prime-Boost Immunization Regimes; Cross-Clade Immunity; Longitudinal Immunity;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses
    Bhat, Sushant
    Sood, Richa
    Shukla, Shweta
    Khandia, Rekha
    Pateriya, Atul Kumar
    Kumar, Naveen
    Singh, Vikas Kumar
    Kalaiyarasu, Semmannan
    Kumar, Manoj
    Bhatia, Sandeep
    VETERINARY MICROBIOLOGY, 2018, 217 : 149 - 157
  • [32] Cross-clade protection against HPAI H5N1 influenza virus challenge in BALB/c mice intranasally administered adjuvant-combined influenza vaccine
    Yang, Penghui
    Tang, Chong
    Luo, Deyan
    Zhan, Zhongpeng
    Xing, Li
    Duan, Yueqiang
    Jia, Weihong
    Peng, Daxin
    Liu, Xiufan
    Wang, Xiliang
    VETERINARY MICROBIOLOGY, 2010, 146 (1-2) : 17 - 23
  • [33] Generation of candidate H5N1 and H9N2 influenza vaccines for pandemic preparedness
    Subbarao, K
    Chen, HL
    Fodor, E
    Mingay, L
    Brownlee, G
    Lu, XH
    Katz, J
    Cox, NJ
    Matsuoka, Y
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1150 - 1150
  • [34] A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge
    Smith, Douglas
    Streatfield, Stephen J.
    Acosta, Hugo
    Ganesan, Shyamala
    Fattom, Ali
    VACCINE, 2019, 37 (42) : 6162 - 6170
  • [35] Oral Priming with Replicating Adenovirus Serotype 4 Followed by Subunit H5N1 Vaccine Boost Promotes Antibody Affinity Maturation and Expands H5N1 Cross-Clade Neutralization
    Khurana, Surender
    Coyle, Elizabeth M.
    Manischewitz, Jody
    King, Lisa R.
    Ishioka, Glenn
    Alexander, Jeff
    Smith, Jon
    Gurwith, Marc
    Golding, Hana
    PLOS ONE, 2015, 10 (01):
  • [36] The safety and immunogenicity of a MF59- adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: An observational study
    Wei S.-H.
    Liu M.-T.
    Tsai Y.-C.
    Liao C.-H.
    Chen C.-M.
    Wang W.-Y.
    Huang Y.-L.
    Chang F.-Y.
    Chou P.
    BMC Infectious Diseases, 14 (1)
  • [37] The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study
    Wei, Sung-Hsi
    Liu, Ming-Tsan
    Tsai, Yao-Chou
    Liao, Chung-Hsin
    Chen, Chih-Ming
    Wang, Wei-Yao
    Huang, Yi-Lung
    Chang, Feng-Yee
    Chou, Pesus
    BMC INFECTIOUS DISEASES, 2014, 14
  • [38] In Vivo Efficacy Evaluation of Vaccines Against H5N1 Influenza Virus
    Mytle, Nutan
    ANTIVIRAL RESEARCH, 2009, 82 (02) : A71 - A71
  • [39] Immunogenicity of Avian H5N1 Influenza Virus Recombinant Vaccines in Cats
    Uhl, Elizabeth W.
    Tompkins, S. Mark
    Harvey, Stephen B.
    Gabbard, Jon
    Michel, Frank
    Perozo, Yaneth
    Hogan, Robert J.
    FASEB JOURNAL, 2010, 24
  • [40] Immunogenicity of Avian H5N1 Influenza Virus Recombinant Vaccines in Cats
    Uhl, Elizabeth W.
    Harvey, Stephen B.
    Michel, Frank
    Perozo, Yaneth
    Gabbard, Jon
    Tompkins, S. Mark
    Hogan, Robert J.
    VIRAL IMMUNOLOGY, 2010, 23 (02) : 221 - 226
12345